These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 21707670)

  • 1. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux pumps of gram-negative bacteria, a new target for new molecules.
    Pagès JM; Sandrine AF; Mahamoud A; Bolla JM; Davin-Regli A; Chevalier J; Garnotel E
    Curr Top Med Chem; 2010; 10(18):1848-57. PubMed ID: 20615189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
    Pagès JM; Amaral L; Fanning S
    Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of AcrB-mediated multidrug export.
    Zwama M; Yamaguchi A
    Res Microbiol; 2018; 169(7-8):372-383. PubMed ID: 29807096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
    Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efflux-mediated Multidrug Resistance in Critical Gram-negative Bacteria and Natural Efflux Pump Inhibitors.
    Nanjan P; Bose V
    Curr Drug Res Rev; 2024; 16(3):349-368. PubMed ID: 38288795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of efflux pump inhibitors to treat Gram-negative infections.
    Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
    Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
    Blair JM; Richmond GE; Piddock LJ
    Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
    Vila J; Martínez JL
    Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug efflux pumps of Gram-positive bacteria.
    Schindler BD; Kaatz GW
    Drug Resist Updat; 2016 Jul; 27():1-13. PubMed ID: 27449594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier.
    Zgurskaya HI; Rybenkov VV; Krishnamoorthy G; Leus IV
    Res Microbiol; 2018; 169(7-8):351-356. PubMed ID: 29454787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
    Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
    Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring the activity of active efflux in gram-negative bacteria.
    Webber MA; Coldham NG
    Methods Mol Biol; 2010; 642():173-80. PubMed ID: 20401594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of efflux pump-based antibiotic resistance.
    Zgurskaya HI
    Int J Med Microbiol; 2002 Jul; 292(2):95-105. PubMed ID: 12195740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
    Wang Y; Venter H; Ma S
    Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of efflux pumps ın antıbıotıc resıstance of gram negatıve rods.
    Başaran SN; Öksüz L
    Arch Microbiol; 2023 Apr; 205(5):192. PubMed ID: 37060362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria.
    Pagès JM; Amaral L
    Biochim Biophys Acta; 2009 May; 1794(5):826-33. PubMed ID: 19150515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hydrophobic trap-the Achilles heel of RND efflux pumps.
    Aron Z; Opperman TJ
    Res Microbiol; 2018; 169(7-8):393-400. PubMed ID: 29146106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.